BryanKyleKeeMD

PubMed

• 1 citations
  Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma.
  Krittiya Korphaisarn, Van K. Morris, Jenifer S. Davis, Michael J. Overman, David R. Fogelman, Bryan K. Kee, Arvind Dasari, Kanwal Pratap Singh Raghav, Imad Shureiqi, M...> ;British Journal of Cancer. 2019 Sep 10
• Anti-EGFR Resistant Clones Decay Exponentially After Progression: Implications for Anti-EGFR Re-challenge.
  Parseghian, C. M.,Loree, J. M.,Morris, V. K.,Liu, X.,Clifton, K. K.,Napolitano, S.,Henry, J. T.,Pereira, A. A.,Vilar, E.,Johnson, B.,Kee, B.,Raghav, K.,Dasari, A.,Wu, ...> ;Ann. Oncol.. 2018 Nov 22
• Physician interpretation of genomic test results and treatment selection.
  Lauren Brusco, Chetna Wathoo, Kenna R. Mills Shaw, Vijaykumar Holla, Ann Marie Bailey, Amber Johnson, Yekaterina B. Khotskaya, Beate C. Litzenburger, Nora S. Sanchez, ...> ;Cancer. 2018 Mar 1
• 13 citations
  FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma.
  Korphaisarn, K., Van Karlyle Morris, Overman, M. J., Fogelman, D. R., Kee, B. K., Raghav, K. P., Manuel, S., Shureiqi, I., Wolff, R. A., Eng, C., Menter, D. G., Hamilt...> ;Oncotarget. 2017 Apr 21
• 6 citations
  Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer.
  Amir Mehrvarz Sarshekeh, Shailesh M Advani, Michael J. Overman, Ganiraju C. Manyam, Bryan K. Kee, David R. Fogelman, Arvind Dasari, Kanwal Pratap Singh Raghav, Eduardo...> ;PLOS ONE. 2017 Mar 7
• 9 citations
  Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction.
  Filip Janku, Haojie Huang, Takeo Fujii, Dawne N. Shelton, Kiran Madwani, S. Fu, Apostolia-Maria Tsimberidou, Sarina Anne Piha-Paul, Jennifer J. Wheler, Ralph Zinner, A...> ;Annals of Oncology. 2016 Dec 19
• 54 citations
  Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation.
  David S. Hong, Van K. Morris, Badi El Osta, Alexey V. Sorokin, Filip Janku, Siqing Fu, Michael J. Overman, Sarina Anne Piha-Paul, Vivek Subbiah, Bryan K. Kee, Apostoli...> ;Cancer Discovery. 2016 Dec 1
• 3 citations
  Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin
  Michael J. Overman, Van K. Morris, Helen Moinova, Ganiraju C. Manyam, Joe Edward Ensor, Michael S. Lee, Cathy Eng, Bryan K. Kee, David R. Fogelman, Rachna T. Shroff, T...> ;Oncotarget. 2016 Aug 16
• 21 citations
  BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System
  Filip Janku, Helen J. Huang, Bart Claes, Gerald S. Falchook, Siqing Fu, David S. Hong, Nishma M. Ramzanali, Giovanni Nitti, Goran Cabrilo, Apostolia Maria Tsimberidou,...> ;Molecular Cancer Therapeutics. 2016 Jun 1
• 13 citations
  Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials
  Michael J. Overman, Van K. Morris, Bryan K. Kee, David R. Fogelman, Lianchun Xiao, Cathy Eng, Arvind Dasari, Rachna T. Shroff, Thibault Mazard, Kenna Rael Shaw, Eduard...> ;Annals of Oncology. 2016 Jun 1
• Capecitabine-induced leukocytoclastic vasculitis under neoadjuvant chemotherapy for locally advanced colorectal cancer.
  Al-Shamsi, H. O., Kee, B. K., Tetzlaff, M. T., Wolff, R. A.> ;Journal of gastrointestinal oncology. 2015 Jun 2
• 1 citations
  Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver.
  Rabih Said, Razelle Kurzrock, Aung Naing, David S. Hong, Siqing Fu, Sarina Anne Piha-Paul, Jennifer J. Wheler, Filip Janku, Bryan K. Kee, Savita Bidyasar, Joann Lim, M...> ;Investigational New Drugs. 2015 May 21
• 38 citations
  Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies.
  Janku, F., Angenendt, P., Tsimberidou, A. M., Fu, S., Naing, A., Falchook, G. S., Hong, D. S., Holley, V. R., Cabrilo, G., Wheler, J. J., Piha-Paul, S. A., Zinner, R. ...> ;Oncotarget. 2015 May 20
• 14 citations
  Phase I study of pazopanib and vorinostat: a therapeutic approach for inhibiting mutant p53-mediated angiogenesis and facilitating mutant p53 degradation
  Siqing Fu, M. M. Hou, Aung Naing, Filip Janku, Kenneth R. Hess, Ralph Zinner, Vivek Subbiah, David S. Hong, Jennifer J. Wheler, Sarina Anne Piha-Paul, Apostolia Maria ...> ;Annals of Oncology. 2015 Feb 10
• 91 citations
  Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
  Maria Pia Morelli, Michael J. Overman, Arvind Dasari, Syed Mohammad Ali Kazmi, Thibault Mazard, Eduardo Vilar, Van K. Morris, Michael Sangmin Lee, Delise H. Herron, Ca...> ;Annals of Oncology. 2015 Jan 26
• 38 citations
  Erratum to "Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies" [Oncotarget., 6 (2015) 12809-1...
  Filip Janku, Philipp Angenendt, Apostolia Maria Tsimberidou, Siqing Fu, Aung Naing, Gerald S. Falchook, David S. Hong, Veronica R. Holley, Goran Cabrilo, Jennifer J. W...> ;Oncotarget. 2015 Jan 1
• 33 citations
  Progression-free survival remains poor over sequential lines of systemic therapy in patients with BRAF-mutated colorectal cancer.
  Van K. Morris, Michael J. Overman, Zhi-Qin Jiang, Christopher R. Garrett, Shweta Agarwal, Cathy Eng, Bryan K. Kee, David R. Fogelman, Arvind Dasari, Robert A. Wolff, D...> ;Clinical Colorectal Cancer. 2014 Sep 1
• A phase II, randomized, double blind trial of calcium aluminosilicate clay versus placebo for the prevention of diarrhea in patients with metastatic colorectal cancer ...
  Kee, B. K., Morris, J. S., Slack, R. S., Crocenzi, T., Wong, L., Esparaz, B., Overman, M. J., Glover, K. Y., Jones, D., Wen, S., Fisch, M. J.> ;Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2014 Aug 28
• 7 citations
  Preoperative chemotherapy prior to pulmonary metastasectomy in surgically resected primary colorectal carcinoma
  Ishwaria Mohan Subbiah, Shanda H. Blackmon, Arlene M. Correa, Bryan K. Kee, Ara A. Vaporciyan, Stephen G. Swisher, Cathy Eng> ;Oncotarget. 2014 Jul 8
• 4 citations
  High prevalence of recurrent thrombosis in subsets of cancer patients with isolated gonadal vein thrombosis: a single center retrospective study.
  Suebpong Tanasanvimon, Naveen Garg, Chitra Viswanathan, Mylene T. Truong, Harmeet Kaur, Bryan K. Kee, Ibrahim Halil Sahin, Milind Javle, Christopher R. Garrett> ;Thrombosis Research. 2014 Feb 1
• 27 citations
  Rare Though Not Mutually Exclusive: A Report of Three Cases of Concomitant KRAS and BRAF Mutation and a Review of the Literature.
  Ibrahim Halil Sahin, Syed Mohammad Ali Kazmi, Jeffrey T. Yorio, Nishin A. Bhadkamkar, Bryan K. Kee, Christo pher R Garrett> ;Journal of Cancer. 2013 Jan 1
• 3 citations
  Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovary.
  Christopher R. Garrett, Ben George, Chitra Viswanathan, Nishin A. Bhadkamkar, Sijin Wen, Veerarabhadran Baladandayuthapani, Y. Nancy You, Edmund S. Kopetz, Michael J. ...> ;Clinical Colorectal Cancer. 2012 Sep 1
• 1 citations
  A Primer on the Current State-of-the-Science Neoadjuvant and Adjuvant Therapy for Patients with Locally Advanced Rectal Adenocarcinomas.
  Jeffrey T. Yorio, Nishin A. Bhadkamkar, Bryan K. Kee, Christopher R. Garrett> ;International Journal of Surgical Oncology. 2012 May 16
• 31 citations
  Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
  Christopher R. Garrett, Hesham M. Hassabo, Nishin A. Bhadkamkar, Sijin Wen, Veerabhadran Baladandayuthapani, Bryan K. Kee, Cathy Eng, Manal Hassan> ;British Journal of Cancer. 2012 Apr 10
• A phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory metastatic colorectal cancer.
  Overman MJ, Eng C, Kee BK, Fogelman DR, Fark C, Hippert R, Holter S, Issa J, Hamilton SR, Kopetz S> ;J. Clin. Oncol.. 2012-02-01
• Join now to see all